Indications for administration of fresh frozen plasma and clotting factor concentrates.
Muntean
W
W
Department of Pediatrics, University of Graz, Austria.
D000990:Antithrombin III / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016913:Blood Component Transfusion / Q000009:adverse effects; D005164:Factor IX / Q000008:administration & dosage / Q000627:therapeutic use; D005167:Factor VII / Q000008:administration & dosage / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D005176:Factor XIII / Q000627:therapeutic use; D015718:Fibrin Tissue Adhesive / Q000627:therapeutic use; D005340:Fibrinogen / Q000627:therapeutic use; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D010949:Plasma; D011486:Protein C / Q000627:therapeutic use; D011516:Prothrombin / Q000627:therapeutic use
D001779:Blood Coagulation Factors; D015718:Fibrin Tissue Adhesive; D006490:Hemostatics; D011486:Protein C; D000990:Antithrombin III; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005340:Fibrinogen; D005176:Factor XIII; C065655:anti-inhibitor coagulant complex